Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anger attacks in patients with depression.

M Fava1, J F Rosenbaum

  • 1Outpatient Psychiatry Division, Massachusetts General Hospital, and Harvard Medical School, Boston 02114, USA.

The Journal of Clinical Psychiatry
|July 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spine surgery and complication in familial dysautonomia: a case report.

Frontiers in surgery·2025
Same author

Promoting resilience in healthcare workers during the COVID-19 pandemic with a brief online intervention.

Journal of psychiatric research·2021
Same author

A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder.

Molecular psychiatry·2019
Same author

Salience network coupling is linked to both tobacco smoking and symptoms of attention deficit hyperactivity disorder (ADHD).

Drug and alcohol dependence·2017
Same author

Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1].

Journal of affective disorders·2017
Same author

Revisiting the role of the insula and smoking cue-reactivity in relapse: A replication and extension of neuroimaging findings.

Drug and alcohol dependence·2017
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Sudden, intense anger attacks, distinct from panic attacks, affect 30-40% of depressed patients. Treatments like fluoxetine can significantly reduce or eliminate these anger episodes.

Area of Science:

  • Psychiatry
  • Clinical Psychology

Background:

  • Anger attacks are sudden, intense episodes of anger.
  • They lack the fear and anxiety typical of panic attacks.
  • These attacks occur when individuals feel trapped, leading to uncharacteristic outbursts.

Purpose of the Study:

  • To explore the concept and development of anger attacks.
  • To examine the prevalence of anger attacks in depression and other psychiatric conditions.
  • To review current treatment strategies for anger attacks.

Main Methods:

  • Review of the literature on anger attacks.
  • Discussion of diagnostic criteria and assessment tools like the Anger Attacks Questionnaire.
  • Analysis of treatment outcomes for anger attacks in depressed patients.

Related Experiment Videos

Main Results:

  • Anger attacks are prevalent in 30% to 40% of patients with depression.
  • Pharmacological treatments, including fluoxetine, sertraline, and imipramine, have shown efficacy.
  • Between 53% and 71% of depressed patients experienced resolution of anger attacks with these medications.

Conclusions:

  • Anger attacks are a recognized phenomenon in psychiatric disorders, particularly depression.
  • Effective pharmacological treatments exist for managing anger attacks.
  • Further research into the underlying mechanisms and comprehensive treatment is warranted.